With high hopes, Eli Lilly's Mounjaro (tirzepatide) was promoted to the big leagues in the week ending May 14, when...
Read moreThe US Food and Drug Administration recently announced that the Johnson & Johnson/Janssen COVID-19 vaccine's urgent use permit will be...
Read moreAccording to a trio of prominent US Food and Drug Administration experts, the US may need to update its COVID-19...
Read moreBristol Myers Squibb has gained approval for one of the year's most anticipated medications, following a brief delay in November....
Read moreThe pharma version of Fast and Furious has a new superhero. How else to characterise AbbVie's Rinvoq's breakthrough effectiveness? The...
Read moreThe FDA's Office of Prescription Medicine Promotion (OPDP) intends to know how patients and doctors consider the risks and benefits of...
Read moreInsulet added to its portfolio of life-changing diabetes management technologies when its Omnipod 5 received FDA clearance in January. Omnipod...
Read moreThe phase 2/3 clinical trials for Bharat Biotech's COVID-19 vaccine, Covaxin, in the United States have been halted by the...
Read moreJSR Life Sciences, LLC, a group company of JSR Corporation, announced that its lead product, Amsphere™ A3 has been incorporated...
Read moreThe FDA approved the AstraZeneca and Merck medications for a select subset of individuals with severe early-stage breast cancer, after...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.